☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CHMP’s Positive Opinion
AstraZeneca and MSD's Lynparza (Olaparib) Receives the CHMP's Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanc...
September 21, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.